20 October 2022
Pirbright to join efforts in monkeypox research as part of new consortium
The Pirbright Institute is taking a lead role in a new monkeypox consortium. The group will work together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness and the virus’ spread. The Monkeypox Consortium has received £2million investment from the…
Read more
